Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Niels MR van der Sangen, I Tarik Küçük, Jurriën M ten Berg, Marcel AM Beijk, Ronak Delewi, Alexander W den Hartog, Yolande Appelman, Niels JW Verouden, Wouter J Kikkert, José PS Henriques & Bimmer EPM Claessen. (2022) P2Y12-inhibitor monotherapy after coronary stenting: are all P2Y12-inhibitors equal?. Expert Review of Cardiovascular Therapy 20:8, pages 637-645.
Read now
Read now
J. Wouter Jukema, Jean-Philippe Collet & Leonardo De Luca. (2012) Antiplatelet therapy in patients with ST-elevation myocardial infarction undergoing myocardial revascularisation: beyond clopidogrel. Current Medical Research and Opinion 28:2, pages 203-211.
Read now
Read now
Hussam M Tayeb, Adam J Nelson, Scott R Willoughby & Matthew I Worthley. (2011) Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Related Outcome Measures 2, pages 7-19.
Read now
Read now
Dominick J Angiolillo, Marco Roffi & Antonio Fernandez-Ortiz. (2011) Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus. Expert Review of Cardiovascular Therapy 9:6, pages 697-710.
Read now
Read now
Juan V Llau, Raquel Ferrandis, Pilar Sierra & Aurelio Gómez-Luque. (2010) Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update. Vascular Health and Risk Management 6, pages 855-867.
Read now
Read now
Articles from other publishers (24)
Mi‐Jo Kim, Hyungsub Kim, Sang‐Min Lee, Hee‐Youn Choi, Yo‐Han Kim, Seung Chan Choi, Eun‐Hwa Kim, Hyun‐Jung Park & Hyeong‐Seok Lim. (2022) Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of Prasugrel in Healthy Male Volunteers. Clinical Pharmacology in Drug Development 12:1, pages 21-29.
Crossref
Crossref
Timothy Abrahams, Adam Brown & Derk Pol. (2022) Prescribing Trends and Health Care Expenditure of P2Y12 Prescriptions in Australia Over the Last Decade. Heart, Lung and Circulation 31:10, pages 1369-1375.
Crossref
Crossref
Rahul Chaudhary, Akanksha Mohananey, Sharan P. Sharma, Sahib Singh, Amteshwar Singh & Ashok Kondur. (2021) Improving Outcomes in Cardiovascular Diseases: A Review on Vorapaxar. Cardiology in Review 30:5, pages 241-246.
Crossref
Crossref
Kamal Kishore, Seenu M. Hariprasad & Sudhir Mungee. (2022) Perioperative Antiplatelet Agents and Anticoagulants in Vitreoretinal Surgery. Ophthalmic Surgery, Lasers and Imaging Retina 53:2, pages 71-78.
Crossref
Crossref
Ghina’a Ismail Abu Deiab, Loai Mohammed Saadah & Iman Amin Basheti. (2022) Using drug chemical structures in the education of pharmacology and clinical therapeutics key concepts. Brazilian Journal of Pharmaceutical Sciences 58.
Crossref
Crossref
Zvonimir Ostojić. (2021) Antiplatelet Therapy with Prasugrel and Ticagrelor in the Treatment of Patients with Acute Coronary Syndrome. Cardiologia Croatica 16:7-8, pages 269-275.
Crossref
Crossref
Mohamed S. Abbas, Mahmoud S. Abbas, Ali N. Harb, Roger K. Kakos, Kristian Loveridge & Hani H. Abujudeh. (2021) Periprocedural Anticoagulation and Antiplatelet Medications Management for Interventional Radiology Procedures. Current Radiology Reports 9:5.
Crossref
Crossref
Hassan Kamran, Hani Jneid, Waleed T. Kayani, Salim S. Virani, Glenn N. Levine, Vijay Nambi & Umair Khalid. (2021) Oral Antiplatelet Therapy After Acute Coronary Syndrome. JAMA 325:15, pages 1545.
Crossref
Crossref
Anton Mararenko, Abbas Alshami, Mohammed AlAzzawi & Swapnil V Patel. (2021) Anticoagulants Used in Cardiac Catheterization of Patients With Chronic Lymphocytic Leukemia: A Case Report and Overview. Cureus.
Crossref
Crossref
Hayden Bell, Brendan Steinfort, Leonardo Pasalic & Mark Dexter. (2020) Failure of platelet function analyser 200 to demonstrate clinical clopidogrel resistance in a patient undergoing intracranial vascular stenting. BMJ Case Reports 13:3, pages e233947.
Crossref
Crossref
E. Kikovska-Stojanovska, Christopher M. Riley, A.M. Clarke & R.L. Phelps. 2020. Specification of Drug Substances and Products. Specification of Drug Substances and Products
195
246
.
Gi-Ho Son, Young-Guk Na, Hyun Wook Huh, Miao Wang, Min-Ki Kim, Min-Gu Han, Jin-Ju Byeon, Hong-Ki Lee & Cheong-Weon Cho. (2019) Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity. Pharmaceutics 11:5, pages 222.
Crossref
Crossref
Carey Kimmelstiel, Ryan Stevenson, Nga Nguyen, Layla Van Doren, Ping Zhang, James Perkins, Navin K. Kapur, Andrew Weintraub, Vilma Castaneda, Athan Kuliopulos & Lidija Covic. (2019) Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel. Thrombosis Research 177, pages 59-69.
Crossref
Crossref
Punag Divanji & Kendrick Shunk. (2018) Modern Antiplatelet Therapy: When Is Clopidogrel the Right Choice?. Cardiovascular Innovations and Applications 3:2.
Crossref
Crossref
Yue Zhang, János Peti-Peterdi, Anna U. Brandes, Anne Riquier-Brison, Noel G. Carlson, Christa E. Müller, Carolyn M. Ecelbarger & Bellamkonda K. Kishore. (2017) Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice. Purinergic Signalling 13:2, pages 239-248.
Crossref
Crossref
Jinesh Bahubali Nagavi, Bannimath Gurupadayya & Preethi Gotadake Anantharaju. (2016) Omeprazole and atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation in patients undergoing percutaneous coronary intervention in a tertiary health care system: A prospective drug–drug interaction study. IJC Metabolic & Endocrine 13, pages 35-40.
Crossref
Crossref
Pierre Sabouret & Magali Taiel-Sartral. (2014) New antiplatelet agents in the treatment of acute coronary syndromes. Archives of Cardiovascular Diseases 107:3, pages 178-187.
Crossref
Crossref
Guillaume Cayla, Johanne Silvain, Stephen A. O'Connor, Jean-Philippe Collet & Gilles Montalescot. (2013) An evidence-based review of current anti-platelet options for STEMI patients. International Journal of Cardiology 166:2, pages 294-303.
Crossref
Crossref
M.S. Hiremath, Rajnesh Kapoor, B.G. Muralidhara, P.C. Manoria, Sunila Lhila & Dhiman Kahali. (2013) WITHDRAWN: Prasugrel therapy in ACS PCI patients: In-practice usage and performance (IPUP) study in Indian patients. Indian Heart Journal.
Crossref
Crossref
G. Cayla, J. Silvain, S. A. O'Connor, J.- P. Collet & G. Montalescot. (2012) Current antiplatelet options for NSTE-ACS patients. QJM 105:10, pages 935-948.
Crossref
Crossref
Patrick A. Laird & Susan D. Ruppert. (2012) Stent Thrombosis in a Clopidogrel Nonresponder. Critical Care Nursing Quarterly 35:2, pages 151-159.
Crossref
Crossref
Lynette R. Moser, Carrie W. Nemerovski & Kelley L. Good. (2011) Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention. Cardiovascular Drugs and Therapy 25:3, pages 267-276.
Crossref
Crossref
Isaac Lynch, Daniel A. Emmert & Michael H. Wall. (2011) Perioperative Considerations and Management in Patients with Intravascular Stents. Advances in Anesthesia 29:1, pages 85-112.
Crossref
Crossref
Chadi Dib, Elias B. Hanna & Mazen S. Abu-Fadel. (2010) A New Era for Antiplatelet Therapy in Patients With Acute Coronary Syndrome. The American Journal of the Medical Sciences 340:5, pages 407-411.
Crossref
Crossref